Members

Dr. Jyothi U. Menon is an Associate Professor of Biomedical Engineering at Texas A&M University. She earned her B.S. and M.S. degrees in Biology/ Biomedical Engineering through the University of Texas (UT) at Arlington – UT Southwestern Medical Center, Dallas Joint program. She then completed her Ph.D. in Biomedical Engineering in the same program. Following her doctoral studies, she completed her postdoctoral training at the University of Oxford, UK in the Department of Radiation Oncology and the Oxford Institute of Biomedical Engineering. She began her independent academic career at the University of Rhode Island in 2017, and transitioned to her current position at Texas A&M University in 2025 where her lab is working at the interface of nanotechnology and tissue engineering to develop targeted drug delivery approaches against cancer and fibrosis with a focus on diseases affecting the lungs and liver.

Dr. Lopamudra Das Ghosh
PhD. Medical Science & Technology, Indian Institute of Technology Kharagpur, India
MSc. Molecular Biology & Biotechnology, University of Kalyani, India
BSc. Microbiology, University of Calcutta, India

I have multi-disciplinary research experience, and my expertise includes stem cells & tissue engineering, organ-on-chip and cancer biology.
My research work focus on developing an in vitro model system to enable real time, dynamic monitoring of structural and functional changes associated with the progression of liver injury and fabricating nanoparticle-based drug delivery system for targeted therapeutics.

John Eloyi Judith

MSc. Pharmaceutical and Industrial Sciences, Ahmadu Bello University, Zaria, Nigeria
B.Pharm. Pharmaceutical Sciences, University of Jos, Plateau, Nigeria

A decrease in the pH of the liver’s microenvironment, often due to chronic inflammation and fibrosis, has prompted the need for pH-targeted drug delivery systems. Leveraging my MSc in nanotechnology, I am developing smart polymeric nanomaterials for antifibrotic drug delivery to treat liver disease. I also aim to utilize 3D printing and organ-on-chip technology to provide highly predictive in vitro models for studying liver disease progression, drug toxicity, and therapeutic responses.

Tandi Ford
Tandi is working on the development of targeted drug delivery systems for the treatment of chronic liver fibrosis.

Armaan Sanghvi
Armaan is developing and characterizing novel bioinks for DLP-based 3D bioprinting applications